Less than three years after announcing plans for a large expansion in Morrisville, a California company focused on genetic testing has filed for bankruptcy.
Invitae (OTC: NVTA) on Feb. 13 filed for Chapter 11 bankruptcy protection as it pursues a sale of its business. The move follows months of layoffs and divestments of business units as the company tried to improve its cash position. While these initiatives helped with cash flow, the company’s debt remains a problem, CEO Ken Knight said in a statement.
The company, in its filing in U.S. Bankruptcy Court in New Jersey, lists total assets of $535 million and total debts at around $1.62 billion.
Invitae’s debt problems are tied to a streak of rapid acquisition activity, with the company completing 13 deals between 2019 and 2021. These transactions required large sums of capital and increased the company’s operating expenses. Invitae funded these deals by adding significant debt to its balance sheet, increasing its debt obligations by about $1.5 billion, according to court filings.
Invitae in April 2021 announced plans for a new testing and laboratory facility in Morrisville. The company later that year signed a lease for all 245,159 square feet of office, research and lab space at a new development called The Stitch – the former site of the Morrisville Outlet Mall off Airport Boulevard right off Interstate 40.
The lease term runs through 2035.
Triad Business Journal









